A citation-based method for searching scientific literature

Timothy M Nywening, Andrea Wang-Gillam, Dominic E Sanford, Brian A Belt, Roheena Z Panni, Brian M Cusworth, Adetunji T Toriola, Rebecca K Nieman, Lori A Worley, Motoyo Yano, Kathryn J Fowler, A Craig Lockhart, Rama Suresh, Benjamin R Tan, Kian-Huat Lim, Ryan C Fields, Steven M Strasberg, William G Hawkins, David G DeNardo, S Peter Goedegebuure, David C Linehan. Lancet Oncol 2016
Times Cited: 390







List of co-cited articles
1997 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis.
Bin-Zhi Qian, Jiufeng Li, Hui Zhang, Takanori Kitamura, Jinghang Zhang, Liam R Campion, Elizabeth A Kaiser, Linda A Snyder, Jeffrey W Pollard. Nature 2011
27

Inflammatory monocyte mobilization decreases patient survival in pancreatic cancer: a role for targeting the CCL2/CCR2 axis.
Dominic E Sanford, Brian A Belt, Roheena Z Panni, Allese Mayer, Anjali D Deshpande, Danielle Carpenter, Jonathan B Mitchem, Stacey M Plambeck-Suess, Lori A Worley, Brian D Goetz,[...]. Clin Cancer Res 2013
350
27

CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models.
Yu Zhu, Brett L Knolhoff, Melissa A Meyer, Timothy M Nywening, Brian L West, Jingqin Luo, Andrea Wang-Gillam, S Peter Goedegebuure, David C Linehan, David G DeNardo. Cancer Res 2014
722
26

CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans.
Gregory L Beatty, Elena G Chiorean, Matthew P Fishman, Babak Saboury, Ursina R Teitelbaum, Weijing Sun, Richard D Huhn, Wenru Song, Dongguang Li, Leslie L Sharp,[...]. Science 2011
25

Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy.
Carola H Ries, Michael A Cannarile, Sabine Hoves, Jörg Benz, Katharina Wartha, Valeria Runza, Flora Rey-Giraud, Leon P Pradel, Friedrich Feuerhake, Irina Klaman,[...]. Cancer Cell 2014
791
25

Targeting macrophages: therapeutic approaches in cancer.
Luca Cassetta, Jeffrey W Pollard. Nat Rev Drug Discov 2018
640
22

PI3Kγ is a molecular switch that controls immune suppression.
Megan M Kaneda, Karen S Messer, Natacha Ralainirina, Hongying Li, Christopher J Leem, Sara Gorjestani, Gyunghwi Woo, Abraham V Nguyen, Camila C Figueiredo, Philippe Foubert,[...]. Nature 2016
617
22

Tumour-associated macrophages as treatment targets in oncology.
Alberto Mantovani, Federica Marchesi, Alberto Malesci, Luigi Laghi, Paola Allavena. Nat Rev Clin Oncol 2017
21

Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer.
Kenneth J Pienta, Jean-Pascal Machiels, Dirk Schrijvers, Boris Alekseev, Mikhail Shkolnik, Simon J Crabb, Susan Li, Shobha Seetharam, Thomas A Puchalski, Chris Takimoto,[...]. Invest New Drugs 2013
217
20

CSF-1R inhibition alters macrophage polarization and blocks glioma progression.
Stephanie M Pyonteck, Leila Akkari, Alberto J Schuhmacher, Robert L Bowman, Lisa Sevenich, Daniela F Quail, Oakley C Olson, Marsha L Quick, Jason T Huse, Virginia Teijeiro,[...]. Nat Med 2013
20

Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma.
Timothy M Nywening, Brian A Belt, Darren R Cullinan, Roheena Z Panni, Booyeon J Han, Dominic E Sanford, Ryan C Jacobs, Jian Ye, Ankit A Patel, William E Gillanders,[...]. Gut 2018
202
19

Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis.
Laura Bonapace, Marie-May Coissieux, Jeffrey Wyckoff, Kirsten D Mertz, Zsuzsanna Varga, Tobias Junt, Mohamed Bentires-Alj. Nature 2014
410
18

Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages.
Jennifer L Guerriero, Alaba Sotayo, Holly E Ponichtera, Jessica A Castrillon, Alexandra L Pourzia, Sara Schad, Shawn F Johnson, Ruben D Carrasco, Suzan Lazo, Roderick T Bronson,[...]. Nature 2017
294
17

Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses.
Jonathan B Mitchem, Donal J Brennan, Brett L Knolhoff, Brian A Belt, Yu Zhu, Dominic E Sanford, Larisa Belaygorod, Danielle Carpenter, Lynne Collins, David Piwnica-Worms,[...]. Cancer Res 2013
619
17


Role of macrophage targeting in the antitumor activity of trabectedin.
Giovanni Germano, Roberta Frapolli, Cristina Belgiovine, Achille Anselmo, Samantha Pesce, Manuela Liguori, Eugenio Erba, Sarah Uboldi, Massimo Zucchetti, Fabio Pasqualini,[...]. Cancer Cell 2013
538
16

CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma.
Colin W Steele, Saadia A Karim, Joshua D G Leach, Peter Bailey, Rosanna Upstill-Goddard, Loveena Rishi, Mona Foth, Sheila Bryson, Karen McDaid, Zena Wilson,[...]. Cancer Cell 2016
459
16

Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells.
Olivier De Henau, Matthew Rausch, David Winkler, Luis Felipe Campesato, Cailian Liu, Daniel Hirschhorn Cymerman, Sadna Budhu, Arnab Ghosh, Melissa Pink, Jeremy Tchaicha,[...]. Nature 2016
471
15

Tissue-Resident Macrophages in Pancreatic Ductal Adenocarcinoma Originate from Embryonic Hematopoiesis and Promote Tumor Progression.
Yu Zhu, John M Herndon, Dorothy K Sojka, Ki-Wook Kim, Brett L Knolhoff, Chong Zuo, Darren R Cullinan, Jingqin Luo, Audrey R Bearden, Kory J Lavine,[...]. Immunity 2017
264
15

Macrophages as regulators of tumour immunity and immunotherapy.
David G DeNardo, Brian Ruffell. Nat Rev Immunol 2019
621
15

PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity.
Sydney R Gordon, Roy L Maute, Ben W Dulken, Gregor Hutter, Benson M George, Melissa N McCracken, Rohit Gupta, Jonathan M Tsai, Rahul Sinha, Daniel Corey,[...]. Nature 2017
919
14

Macrophage activation and polarization: nomenclature and experimental guidelines.
Peter J Murray, Judith E Allen, Subhra K Biswas, Edward A Fisher, Derek W Gilroy, Sergij Goerdt, Siamon Gordon, John A Hamilton, Lionel B Ivashkiv, Toby Lawrence,[...]. Immunity 2014
14

Phase 2 trial of single agent Ipilimumab (anti-CTLA-4) for locally advanced or metastatic pancreatic adenocarcinoma.
Richard E Royal, Catherine Levy, Keli Turner, Aarti Mathur, Marybeth Hughes, Udai S Kammula, Richard M Sherry, Suzanne L Topalian, James C Yang, Israel Lowy,[...]. J Immunother 2010
711
14

Targeting the CCL2-CCR2 signaling axis in cancer metastasis.
Su Yin Lim, Arseniy E Yuzhalin, Alex N Gordon-Weeks, Ruth J Muschel. Oncotarget 2016
268
13

Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer.
Christine Feig, James O Jones, Matthew Kraman, Richard J B Wells, Andrew Deonarine, Derek S Chan, Claire M Connell, Edward W Roberts, Qi Zhao, Otavia L Caballero,[...]. Proc Natl Acad Sci U S A 2013
13

Human chimeric antigen receptor macrophages for cancer immunotherapy.
Michael Klichinsky, Marco Ruella, Olga Shestova, Xueqing Maggie Lu, Andrew Best, Martha Zeeman, Maggie Schmierer, Konrad Gabrusiewicz, Nicholas R Anderson, Nicholas E Petty,[...]. Nat Biotechnol 2020
288
13


Phase 1b study of a small molecule antagonist of human chemokine (C-C motif) receptor 2 (PF-04136309) in combination with nab-paclitaxel/gemcitabine in first-line treatment of metastatic pancreatic ductal adenocarcinoma.
Marcus Noel, Eileen M O'Reilly, Brian M Wolpin, David P Ryan, Andrea J Bullock, Carolyn D Britten, David C Linehan, Brian A Belt, Eric C Gamelin, Bishu Ganguly,[...]. Invest New Drugs 2020
53
22

Tumor-associated macrophages: from mechanisms to therapy.
Roy Noy, Jeffrey W Pollard. Immunity 2014
12

Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards.
Vincenzo Bronte, Sven Brandau, Shu-Hsia Chen, Mario P Colombo, Alan B Frey, Tim F Greten, Susanna Mandruzzato, Peter J Murray, Augusto Ochoa, Suzanne Ostrand-Rosenberg,[...]. Nat Commun 2016
12

TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy.
Christopher B Rodell, Sean P Arlauckas, Michael F Cuccarese, Christopher S Garris, Ran Li, Maaz S Ahmed, Rainer H Kohler, Mikael J Pittet, Ralph Weissleder. Nat Biomed Eng 2018
383
12

CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages.
Takanori Kitamura, Bin-Zhi Qian, Daniel Soong, Luca Cassetta, Roy Noy, Gaël Sugano, Yu Kato, Jiufeng Li, Jeffrey W Pollard. J Exp Med 2015
387
12

Tumoral Immune Cell Exploitation in Colorectal Cancer Metastases Can Be Targeted Effectively by Anti-CCR5 Therapy in Cancer Patients.
Niels Halama, Inka Zoernig, Anna Berthel, Christoph Kahlert, Fee Klupp, Meggy Suarez-Carmona, Thomas Suetterlin, Karsten Brand, Juergen Krauss, Felix Lasitschka,[...]. Cancer Cell 2016
263
12

Phagocytosis checkpoints as new targets for cancer immunotherapy.
Mingye Feng, Wen Jiang, Betty Y S Kim, Cheng Cheng Zhang, Yang-Xin Fu, Irving L Weissman. Nat Rev Cancer 2019
246
12

Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy.
Michael A Cannarile, Martin Weisser, Wolfgang Jacob, Anna-Maria Jegg, Carola H Ries, Dominik Rüttinger. J Immunother Cancer 2017
455
12

The chemokine system in diverse forms of macrophage activation and polarization.
Alberto Mantovani, Antonio Sica, Silvano Sozzani, Paola Allavena, Annunciata Vecchi, Massimo Locati. Trends Immunol 2004
12

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.
Thierry Conroy, Françoise Desseigne, Marc Ychou, Olivier Bouché, Rosine Guimbaud, Yves Bécouarn, Antoine Adenis, Jean-Luc Raoul, Sophie Gourgou-Bourgade, Christelle de la Fouchardière,[...]. N Engl J Med 2011
11

5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity.
Julie Vincent, Grégoire Mignot, Fanny Chalmin, Sylvain Ladoire, Mélanie Bruchard, Angélique Chevriaux, François Martin, Lionel Apetoh, Cédric Rébé, François Ghiringhelli. Cancer Res 2010
783
11

The cellular and molecular origin of tumor-associated macrophages.
Ruth A Franklin, Will Liao, Abira Sarkar, Myoungjoo V Kim, Michael R Bivona, Kang Liu, Eric G Pamer, Ming O Li. Science 2014
774
11

Reprogramming Tumor-Associated Macrophages by Antibody Targeting Inhibits Cancer Progression and Metastasis.
Anna-Maria Georgoudaki, Kajsa E Prokopec, Vanessa F Boura, Eva Hellqvist, Silke Sohn, Jeanette Östling, Rony Dahan, Robert A Harris, Mattias Rantalainen, Daniel Klevebring,[...]. Cell Rep 2016
306
11

Macrophage biology in development, homeostasis and disease.
Thomas A Wynn, Ajay Chawla, Jeffrey W Pollard. Nature 2013
11

Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study.
Nicholas Butowski, Howard Colman, John F De Groot, Antonio M Omuro, Lakshmi Nayak, Patrick Y Wen, Timothy F Cloughesy, Adhirai Marimuthu, Sam Haidar, Arie Perry,[...]. Neuro Oncol 2016
285
11

Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy.
Russell Hughes, Bin-Zhi Qian, Charlotte Rowan, Munitta Muthana, Ioanna Keklikoglou, Oakley C Olson, Simon Tazzyman, Sarah Danson, Christina Addison, Mark Clemons,[...]. Cancer Res 2015
260
11

Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy.
David G DeNardo, Donal J Brennan, Elton Rexhepaj, Brian Ruffell, Stephen L Shiao, Stephen F Madden, William M Gallagher, Nikhil Wadhwani, Scott D Keil, Sharfaa A Junaid,[...]. Cancer Discov 2011
11

Phase I study of emactuzumab single agent or in combination with paclitaxel in patients with advanced/metastatic solid tumors reveals depletion of immunosuppressive M2-like macrophages.
C A Gomez-Roca, A Italiano, C Le Tourneau, P A Cassier, M Toulmonde, S P D'Angelo, M Campone, K L Weber, D Loirat, M A Cannarile,[...]. Ann Oncol 2019
75
14

BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial.
Bruno Bockorny, Valerya Semenisty, Teresa Macarulla, Erkut Borazanci, Brian M Wolpin, Salomon M Stemmer, Talia Golan, Ravit Geva, Mitesh J Borad, Katrina S Pedersen,[...]. Nat Med 2020
146
11

Cancer-Associated Fibroblasts Neutralize the Anti-tumor Effect of CSF1 Receptor Blockade by Inducing PMN-MDSC Infiltration of Tumors.
Vinit Kumar, Laxminarasimha Donthireddy, Douglas Marvel, Thomas Condamine, Fang Wang, Sergio Lavilla-Alonso, Ayumi Hashimoto, Prashanthi Vonteddu, Reeti Behera, Marlee A Goins,[...]. Cancer Cell 2017
305
11

Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN.
Zvi G Fridlender, Jing Sun, Samuel Kim, Veena Kapoor, Guanjun Cheng, Leona Ling, G Scott Worthen, Steven M Albelda. Cancer Cell 2009
11

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes.
Alberto Mantovani, Silvano Sozzani, Massimo Locati, Paola Allavena, Antonio Sica. Trends Immunol 2002
10

Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets.
Luca Cassetta, Stamatina Fragkogianni, Andrew H Sims, Agnieszka Swierczak, Lesley M Forrester, Hui Zhang, Daniel Y H Soong, Tiziana Cotechini, Pavana Anur, Elaine Y Lin,[...]. Cancer Cell 2019
341
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.